KR100190989B1 - Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof - Google Patents

Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof Download PDF

Info

Publication number
KR100190989B1
KR100190989B1 KR1019960007789A KR19960007789A KR100190989B1 KR 100190989 B1 KR100190989 B1 KR 100190989B1 KR 1019960007789 A KR1019960007789 A KR 1019960007789A KR 19960007789 A KR19960007789 A KR 19960007789A KR 100190989 B1 KR100190989 B1 KR 100190989B1
Authority
KR
South Korea
Prior art keywords
extract
water
soluble fraction
skin whitening
freckles
Prior art date
Application number
KR1019960007789A
Other languages
Korean (ko)
Other versions
KR960033442A (en
Inventor
김호정
이종태
이상화
김정훈
강세훈
Original Assignee
성재갑
주식회사엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사엘지화학 filed Critical 성재갑
Priority to KR1019960007789A priority Critical patent/KR100190989B1/en
Publication of KR960033442A publication Critical patent/KR960033442A/en
Application granted granted Critical
Publication of KR100190989B1 publication Critical patent/KR100190989B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin

Abstract

본 발명은 반하로부터 흑화성분을 제거하여 미백효과가 개선된 반하의 수용성 분획 추출물 및 이를 함유한 기미, 주근깨 개선 및 피부미백용 조성물에 관한 것이다.The present invention relates to a semi-aqueous water-soluble fraction extract having a blackening effect removed from the halves and improving the whitening effect thereof, and a composition for improving blemishes, freckles and skin whitening containing the same.

본 발명의 반하의 수용성 분획 추출물은 반하를 물 , 함수 또는 무수의 탄소수 1~4의 저급 알코올, 에틸아세테이트 또는 아세톤으로 1회 이상 추출하고, 추출액을 감압농축한 후 흑화성분이 함유된 극성용매 분획을 제거한 다음 정제, 건조하여 수용성 분획을 얻는 방법으로 제조된다.Half of the water-soluble fraction extract of the present invention is half or more times extracted with lower alcohol, ethyl acetate or acetone having 1 to 4 carbon atoms, water, anhydrous or anhydrous, and the polar solvent fraction containing blackening component after concentration under reduced pressure And then purified and dried to obtain an aqueous fraction.

본 발명에 따른 조성물은 반하 수용성 분획 추출물을 건조중량으로 0.0001~10중량% 함유하는 것을 특징으로 한다.The composition according to the invention is characterized in that it contains 0.0001 to 10% by weight of a semi-soluble fraction extract in dry weight.

Description

흑화 성분을 제거하여 개선된 미백효과를 갖는 반하 수용성 분획 추출물 및 이를 함유하는 기미, 주근깨 개선 및 피부미백용 조성물Semi-water soluble fraction extract with improved whitening effect by removing blackening components and composition for improving blemishes, freckles and skin whitening containing same

본 발명은 반하추출물에서 흑화성분을 제거함으로써 미백효과를 개선시킨 것을 특징을 하는 반하의 수용성분획 추출물과 이를 함유하는 조성물에 관한 것으로서, 보다 상세하게는 멜라닌생성 억제효과와 미백효과가 우수한 개선된 반하의 수용성 분획 추출물과 이를 함유하는 기미, 주근깨 개선 및 피부미백용 조성물에 관한 것이다.The present invention relates to a water-soluble fraction extract and a composition containing the same, which is characterized in that the whitening effect is improved by removing the blackening component from the halves extract, and more particularly, the improved halves having excellent melanogenesis inhibitory effect and whitening effect. It relates to a water-soluble fraction of the extract and the composition containing the blemishes, freckles and skin whitening.

희고 고운 피부를 갖고자 하는것은 모든 사람의 한결같은 소망이다. 사람의 피부색은 피부내 멜라닌(melanin)의 농도와 분포에 따라 유전적으로 결정되나, 태양 자외선이나 피로, 스트레스 같은 환경적 또는 생리적 조건에 의해서도 영향을 받는다. 멜라닌은 아미노산의 일종인 티로신(tyrosine)에 티로시나제(tyrosinase)라는 효소가 작용하여 도파(dopa), 도파퀴논(dopaquinone)으로 바뀐 후 비효소적인 산화반응을 거쳐 만들어진다. 그러나 멜라닌이 만들어지는 경로는 알려져 있으나, 티로시나제가 작용하는 이전단계인 멜라닌합성을 유도하는 메카니즘(mechanism)이 무엇인지에 대하여는 아직도 자세히 밝혀지지 않고 있다.To have white and fair skin is everyone's constant desire. Human skin color is genetically determined by the concentration and distribution of melanin in the skin, but is also influenced by environmental or physiological conditions such as solar ultraviolet light, fatigue and stress. Melanin is a type of amino acid tyrosine (tyrosine) enzymes called tyrosinase (tyrosinase) acts to convert to dopa (dopa), dopaquinone (dopaquinone) is produced through a non-enzymatic oxidation reaction. However, although the pathway through which melanin is made is known, it is still unknown in detail the mechanism that induces melanin synthesis, which is a prior step of tyrosinase action.

이에 종래에는 하이드로퀴논(tydroquenone)이나 아스콜빈산(ascorbec acid), 고지산 (kojic acid), 글루타치온(glutathione) 같은 티로시나제에 저해활성을 갖는 물질을 연고나 화장료에 배합하여, 피부미백이나 기미, 주근깨 개선의 목적에 사용하여 왔으나, 피부에 자극성을 유발하거나 제품안정성이 좋지 못하여 사용이 제한되고, 또 그 효과도 미약한 단점이 있었다.Therefore, conventionally, a substance having an inhibitory activity on tyrosinase such as hydroquinone, ascorbec acid, kojic acid, glutathione, and the like is added to the ointment or cosmetics, and the skin whitening, blemishes, and freckles are used. Although it has been used for the purpose of improvement, the use is limited because it causes irritation to the skin or poor product stability, and the effect was also weak.

따라서 본 발명자들은 멜라닌 합성유도 자체를 억제하는 물질까지 스크리닝할 수 있는 쥐의 멜라노마 세포(B16 melanoma cell)를 이용하여 천연에서 자생하는 동식물들을 대상으로 새로운 미백제를 개발하여 왔다.Therefore, the present inventors have developed a new whitening agent for animals and plants native to nature using mouse melanoma cells (B16 melanoma cells) that can be screened to a substance that inhibits melanin synthesis induction itself.

일본공개특허 평6-219934호에는 반하, 산약 등의 약재추출물이 쥐 멜라노마세포(b16 melanoma cell)의 색소생합성을 억제한다고 보고한 바 있다.In Japanese Patent Laid-Open No. 6-219934, on the other hand, herbal extracts such as powders have been reported to inhibit the pigment biosynthesis of rat melanoma cells (b16 melanoma cells).

그러나 평6-219934호에서 인용된 반하추출물을 그대로 사용할 경우 효과가 미약하고 또 짙은 흑갈색을 띠어 실제 제품에 적용하기에는 매우 곤란하다. 이에 본 발명자들은 연구에 정진하여 반하추출물에는 미백효과를 갖는 성분 뿐 아니라 오히려 쥐의 멜라노마세표(b16 melaonma cell)를 강력하게 흑화시키는 성분이 다량 혼재되어 있어 전체추출물의 미백효과가 미약하다는 것을 발견하고, 반하추출물로 부터 분리된 흑화성분을 피부흑색제로 특허출원한 바 있다(대한민국 특허출원번호 : 제95-34976호).However, the half-harvest extracts quoted in Pyeong 6-219934, when used as they are, are very difficult to apply to actual products because they have a weak effect and have a dark blackish brown color. Therefore, the present inventors devote to research and found that the half extract has a whitening effect as well as a component that strongly blackens rat melanoma cell (b16 melaonma cell), so that the whitening effect of the whole extract is weak. In addition, the blackening component separated from the halved extract has been patented as a skin blackening agent (Korean Patent Application No. 95-34976).

이어 반하의 추출물에 다량 혼재되어 있는 흑화성분을 제거하면, 추출물 중의 수용성 분획은 미백효과가 획기적으로 개선되며, 또한 수용성 분획을 알칼리로 pH 6.0~13.0으로 조정하여 생긴 백색 침전물이 미백효과를 나타내는 주성분임을 밝혀내고 본 발명을 완성하게 되었다.Subsequently, when the blackening component mixed in a large amount is removed, the water-soluble fraction in the extract significantly improves the whitening effect, and the white precipitate produced by adjusting the water-soluble fraction to pH 6.0-13.0 with alkali is the main component showing the whitening effect. It was found that the present invention has been completed.

본 발명을 상세하게 설명하면 다음과 같다.The present invention will be described in detail as follows.

생약재로 시판되는 반하를 구입하여 잘게 분쇄하고 분쇄물 건조중량에 대하여 5~20부피의 물이나, 탄소수 1~4개의 무수 또는 함수 저급알코올, 에틸아세테이트 또는 아세톤으로 환류냉각기가 달린 추출기에서 50~100℃로 1~5시간 가열하여 추출한다. 여과포로 여과한 후 잔사를 같은 방법으로 1회 이상씩 더 추출한다. 추출액을 합하여 감압 농축한 후 다시 침전을 걸러 내고 농축한다. 이어 농축된 1차 추출물에 정제수를 가하고 물과 섞이지 않는 극성도가 3.0 이상인 극성 유기용매에 녹는 분획을 제거하여 정제한 후 건조시켜 반하 수용성 분획 추출물을 얻는다.Buy half of the medicinal herb and grind it finely, and crush it to 50 ~ 100 in an extractor equipped with reflux cooler with 5 ~ 20 volume of water or 1 ~ 4 carbon number anhydrous or hydrous lower alcohol, ethyl acetate or acetone. Extract by heating to 1 ~ 5 hours. After filtering with a filter cloth, the residue is extracted one more time in the same manner. The extracts were combined, concentrated under reduced pressure, filtered out and concentrated again. Then, purified water is added to the concentrated primary extract, and the fractions dissolved in a polar organic solvent having a polarity of 3.0 or more that is not mixed with water are purified and dried to obtain a semi-soluble fraction extract.

또한 정제된 반하 수용성 분획 추출물에 알칼리를 가해 백색 침전물을 얻는다.In addition, alkali is added to the purified semi-soluble fraction extract to obtain a white precipitate.

이와 같이 얻어진 정제물을 일본공개특허 평6-219934호에서의 반하총추출물과 비교하여 쥐의 멜라노마 세포(B16 melanoma cell)에 적용해 본 결과, 반하의 총추출물에서는 미백효과가 없거나 매우 미약한 반면, 본 발명에서와 같이 멜라닌 합성을 촉진하는 흑화성분을 제거하면 미백효과가 10배 이상 획기적으로 중대되며 알칼리 상태에서 더욱 정제된 침전물은 백색도가 뛰어나고 미백성분이 농축되어 연고나 로션 등의 피부미백제를 제조하여도 제품의 색상이나 제형에 전혀 문제가 없으며 사람의 피부에 도포하였을 때도 안전하고 뛰어난 미백효과를 나타낸다는 것을 확인할 수 있었다. 그러나 흑화성분이 제거되지 않는 반하 총추출물은 미백효과를 기대하기 어려웠으며 오히려 자극성이 있으며 제품에서도 흑갈색이 나타나는 등 제형에도 문제가 있었다.As a result of applying the purified product thus obtained to the rat melanoma cells (B16 melanoma cells) compared to the half-half total extract in Japanese Patent Laid-Open No. 6-219934, the half-half total extract has no whitening effect or is very weak. On the other hand, when the blackening component that promotes melanin synthesis is removed as in the present invention, the whitening effect is significantly more than 10 times, and the precipitate further purified in an alkaline state has excellent whiteness and the whitening component is concentrated, such as ointment or lotion. Even if manufactured, there was no problem in the color or formulation of the product, and even when applied to human skin, it was confirmed that it shows a safe and excellent whitening effect. However, the total extract, which does not remove the blackening component, was difficult to expect a whitening effect, rather irritating, and there was a problem in the formulation, such as blackish brown in the product.

피부외용연고나 화장표제조시에 함유되는 본 발명의 반하 수용성 분획 추출물의 함량은 건조중량으로 0.0001~10중량%가 적당하다. 0.0001중량% 이하의 농도에서는 뚜렷한 효과를 기대할 수 없었고, 10중량% 이상의 농도에서는 함유량의 증가에 따라 뚜렷한 효과의 증가가 나타나지 않았다.The content of the semi-soluble water extract fraction of the present invention contained in skin external ointment or cosmetic preparation is suitable for the dry weight of 0.0001 ~ 10% by weight. A clear effect could not be expected at concentrations below 0.0001% by weight, and no increase in effect was seen at concentrations above 10% by weight.

다음에 실시예, 비교예 및 실험예에 의거하여 본 발명을 자세히 설명하고자 하며, 본 발명이 실시예에만 한정괴는 것이 아님을 밝혀둔다Next, the present invention will be described in detail with reference to Examples, Comparative Examples, and Experimental Examples, and the present invention is not limited to Examples.

[비교예 1]Comparative Example 1

반하의 괴경 분쇄물 300g을 80% 메탄올용액 1.5ℓ에 넣고, 냉각콘덴서가 달린 환류추출기에서 3시간 끓여 추출한 다음, 300메쉬 여과포로 여과한 후 잔사를 같은 방법으로 1회 더 추출하였다. 추출액을 상온에서 화트만(whatman) 2번 여과지로 침전을 걸러내어 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축한 후 분무건조하여 건조중량 12.1g을 얻었다.The lower tuber pulverized product was put into 1.5 L of 80% methanol solution, boiled for 3 hours in a reflux extractor equipped with a cooling capacitor, filtered through a 300 mesh filter cloth, and the residue was extracted once more in the same manner. The extract was filtered out of whatman No. 2 filter paper at room temperature, concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser, and then spray-dried to obtain a dry weight of 12.1 g.

[비교예 2]Comparative Example 2

비교예 1에서 얻어진 반하의 1차 추출물에 정제수 120ml를 첨가하고 동량의 노말 헥산을 가하여 잘 섞은후 노말 헥산 분획을 게거하고 여액에 동량의 메칠렌클로라이드를 첨가하여 잘 섞은 후 메칠렌크로라이드 분획을 얻는 과정을 3회 반복하여 냉각 콘덴서가 달린 증류 장치에서 40℃에서 감압농축하여 건조중량 1.2g을 얻었다.120 ml of purified water was added to the first half extract obtained in Comparative Example 1, the same amount of normal hexane was added to the mixture, and the mixture was mixed well. Then, the normal hexane fraction was removed, and the same amount of methylene chloride was added to the filtrate. The process of obtaining was repeated three times and concentrated under reduced pressure at 40 ° C. in a distillation apparatus equipped with a cooling condenser to obtain a dry weight of 1.2 g.

[비교예 3]Comparative Example 3

비교예 2에서 얻은 여액에 동량의 노말부탄올을 첨가하여 잘 섞은 후 노말부탄올의 분획을 얻는 과정을 3회 반복하여 냉각 콘덴서가 달린 증류장치에서 50℃로 감압농축하여 건조중량 2.5g을 얻었다.After adding the same amount of normal butanol to the filtrate obtained in Comparative Example 2 and mixing it well, the process of obtaining a fraction of normal butanol was repeated three times, and concentrated under reduced pressure at 50 ° C. in a distillation apparatus equipped with a cooling condenser to obtain a dry weight of 2.5 g.

[실시예 1]Example 1

비교예 3에서 얻은 여액(수용성 분획)을 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축하여 건조중량 7.4g을 얻었다.The filtrate (water-soluble fraction) obtained in Comparative Example 3 was concentrated under reduced pressure at 60 ° C. in a distillation apparatus with a cooling condenser to obtain a dry weight of 7.4 g.

[비교예 4][Comparative Example 4]

반하의 괴경 분쇄물 300g을 50℃에서 일본공개특허 평6-219934호에 따른 방법으로 실시하여 건조중량 10.5g을 얻었다.The lower tuber pulverized product 300g was performed at 50 degreeC by the method of Unexamined-Japanese-Patent No. 6-219934, and the dry weight of 10.5g was obtained.

[비교예 5][Comparative Example 5]

비교예 4에서 얻은 반하 추출물 10.5g에 정제수 100ml를 첨가하고 비교예 2와 같은 방법으로 실시하여 건조중량 0.9g를 얻었다.100 ml of purified water was added to 10.5 g of the halves extract obtained in Comparative Example 4, and the drying was performed in the same manner as in Comparative Example 2 to obtain a dry weight of 0.9 g.

[비교예 6]Comparative Example 6

비교예 5에서의 여액을 비교에 3과 같은 방법으로 실시하여 건조중량 2.1g을 얻었다.The filtrate in Comparative Example 5 was subjected to the same method as in Comparative 3 to obtain 2.1 g of a dry weight.

[실시예 2]Example 2

비교예 6에서의 여액(수용성 분획)을 실시예 1과 같은 방법으로 실시하여 건조중량 6.8g을 얻었다.The filtrate (aqueous fraction) in Comparative Example 6 was carried out in the same manner as in Example 1 to obtain a dry weight of 6.8 g.

[실시예 3]Example 3

실시예 1에서의 건조물에 정제수 35ml를 넣고 수산와 나트륨 용액으로 pH 12.5로 적정하고 원심분리하여 얻어진 백색 침전물을 냉각 콘덴서가 달린 증류장치에서 60℃로 감압농축하여 건조중량 0.5g을 얻었다.35 ml of purified water was added to the dried product of Example 1, the reaction mixture was titrated to pH 12.5 with sodium hydroxide and sodium solution, and the white precipitate obtained by centrifugation was concentrated under reduced pressure at 60 ° C. in a distillation apparatus equipped with a cooling condenser to obtain a dry weight of 0.5 g.

[실험예 1]Experimental Example 1

상기 실시예 1~3과 비교예 1~6에서 얻어진 각 추출물들을 귀의 멜라노마 세포(B16 mouse melanoma cell)의 배양액에 첨가하여 세포수준에서의 미백효과를 실험하였다(Lotan r., Lotan d. Cancer Res. 40:3345-3350, 1980). 실시예 1~3과 비교예 1~6에서 얻어진 각 추출물들과 하이드로 퀴논을 각각 쥐 멜라노마(B16 melanoma cell)세포의 배양 배지에 첨가하여 3일간 배양한 후 세포들을 트립신(trypsin)처리하여 배양용기로부터 떼어내 원심분리한후 멜라닌을 추출하였다. 이것에 수산화나트륨 용액(1N 농도) 1ml를 가하여 10분간 끓여 멜라닌을 녹이고 분광 광도계를 이용, 400나노미터(nm)에서 흡광도를 측정하여 생성된 멜라닌의 양을 단위 세포수당(106cell)의 흡광도로 나타내는 방법으로 수행하였으며, 대조군에 대한 상대적인 멜라닌 생성량을 저해율(%)로 계산하고 결과를 표 1에 정리하였다.Each of the extracts obtained in Examples 1 to 3 and Comparative Examples 1 to 6 were added to the culture solution of ear melanoma cells (B16 mouse melanoma cells) to test the whitening effect at the cellular level (Lotan r., Lotan d. Cancer Res. 40: 3345-3350, 1980). Each of the extracts obtained in Examples 1 to 3 and Comparative Examples 1 to 6 and hydroquinone were added to the culture medium of rat B16 melanoma cells, and then cultured for 3 days, followed by trypsin treatment. The melanin was extracted after centrifugation and removal from the vessel. To this, 1 ml of sodium hydroxide solution (1N concentration) was added, boiled for 10 minutes to dissolve melanin, and the absorbance was measured at 400 nanometers (nm) using a spectrophotometer to measure the amount of melanin produced per unit cell number (10 6 cells) It was performed by the method shown as, the relative melanin production relative to the control was calculated as the inhibition rate (%) and the results are summarized in Table 1.

상기 결과에서 알 수 있듯이, 비교예 2~3을 대조군과 비교하면 반하 추출물의 솔벤트 분획에는 극미량의 적용 농도임에도 불구하고 멜라닌 생성을 강력하게 촉진하는 흑화성분이 존재함을 알수 있다. 그러나 본 발명에 따른 실시예 1과 같이 흑화성분을 제거한 수용성 분획은 비교예 1과 같은 농도에서 미백효과가 10배 이상 획기적으로 증대함을 알 수 있다. 따라서 반하 총추출물의 미약한 미백효과는 멜라닌 생성을 촉진하는 흑화성분이 멜라닌 생성 억제효과를 상쇄시켜 나타나는 현상임을 알 수 있다. 또 일본공개 특허 평6-219934호에 따른 비교예 4에 비교예 5와 6의 흑화성분이 존재하여 미백효과가 매우 미약한, 흑화성분을 제거한 실시예 2의 경우는 미백효과가 마찬가지로 현저히 개선되어짐을 알 수 있다As can be seen from the above results, it can be seen that when compared to the control example of Comparative Examples 2 to 3, the solvent fraction of the lower extract has a blackening component that strongly promotes melanin production despite the application amount of the trace amount. However, it can be seen that the water-soluble fraction from which the blackening component is removed as in Example 1 according to the present invention increases the whitening effect by more than 10 times at the same concentration as in Comparative Example 1. Therefore, it can be seen that the weakening whitening effect of the total extract is a phenomenon in which blackening components that promote melanin production cancel the melanin production inhibitory effect. In addition, the whitening effect is remarkably improved in Example 2, in which blackening component of Comparative Examples 5 and 6 is present in Comparative Example 4 according to Japanese Patent Laid-Open No. 6-219934 and the blackening component is very weak. I can see

또한, 반하의 수용성 분획을 더욱 정제한 실시예 3의 미백효과는 실시예 1에 비해 13배 이상 향상되어 소량 적용할 수 있으며, 백식 분말로서 제품 적용시에도 전혀 제품의 색상에 문제가 없음을 알 수 있다.In addition, the whitening effect of Example 3, which further refines the water-soluble fraction of the lower half, is 13 times higher than that of Example 1, and can be applied in small amounts. As a white powder, it is understood that there is no problem in the color of the product at all. Can be.

[실험예 2]Experimental Example 2

실험예 1과 같은 방법으로 배양된 쥐의 멜라노마 세포에 대하여 실시예 3의 추출물에 대하여 농도에 따른 멜라닌 생성 억제능을 조사하였으면 결과는 표 2와 같다.When the melanin production inhibitory ability of the rat melanoma cells cultured in the same manner as in Experimental Example 1 was investigated according to the concentration, the results are shown in Table 2.

위의 결과에서 볼 수 있듯이, 실시예 3의 추출물은 배양된 쥐 멜라노마 세포에 대하여 매우 강력한 멜라닌 생성 억제능을 가지고 있으며, 실시예 3의 추출물의 농도에 따라 0.0001%에서 0.1%이상까지 멜라닌 생성 억제능이 증가한다. 또한 하이드로퀴논이 미백효과는 우수하나, 세포의 성장을 어제하고 세포형태를 변화시키는 등의 세포독성으로 0.0001%이상에서는 실험을 할 수 없는 것에 반하여, 실시예 3의 추출물은 0.1%농도에서도 세포독성을 나타내지 않으면서 하이드로퀴논보다 높은 멜라닌 생성 억제능을 갖는다.As can be seen from the above results, the extract of Example 3 has a very strong melanin production inhibitory ability against cultured mouse melanoma cells, and melanin production inhibitory ability from 0.0001% to 0.1% or more depending on the concentration of the extract of Example 3 This increases. In addition, hydroquinone is excellent in whitening effect, but can not be experimented at 0.0001% or more due to cytotoxicity such as yesterday's cell growth and cell type change, extract of Example 3 is cytotoxic even at 0.1% concentration It has higher melanin production inhibition than hydroquinone without showing.

이하에 실시예의 추출물을 함유하는 피부미백용 조성물의 처방예를 제조예에 의해 나타내었다.The preparation example of the skin whitening composition containing the extract of the Example below is shown by the manufacture example.

[제조예 1][Production Example 1]

반하추출물을 함유하는 피부 외용 연고 처방예는 다음과 같다.An example of the external preparation of the ointment for the skin containing the half-harvest extract is as follows.

여기서 반하추출물을 실시예 1의 것을 말한다.Herein, the semi-half extract refers to that of Example 1.

[제조예 2 및 비교제조예 1]Production Example 2 and Comparative Production Example 1

반하추출물을 함유하는 화장료 중 크림의 처방예는 다음과 같다.A prescription example of a cream in cosmetics containing a half herb extract is as follows.

여기서 반하추출물은 실시예 3의 것을 말한다.Here, the half extract refers to that of Example 3.

[제조예 3 및 비교제조예 2]Production Example 3 and Comparative Production Example 2

반하추출물을 함유한 화장료 중 유연화장수의 처방예는 다음과 같다.Prescription examples of the flexible cosmetics in the cosmetics containing the semi-half extract are as follows.

여기서 반하추출물은 실시예 3의 것을 말한다.Here, the half extract refers to that of Example 3.

[제조예 4 및 비교제조예 3]Production Example 4 and Comparative Production Example 3

반하추출물을 함유한 화장료 중 영양화장수의 처방예는 다음과 같다.An example of the prescription of nutrient cosmetics in cosmetics containing half the extract is as follows.

여기서 반하추출물은 실시예 3의 것을 말한다.Here, the half extract refers to that of Example 3.

[제조예 5 및 비교제조예 4]Production Example 5 and Comparative Production Example 4

반하추출물을 함유한 화장료 중 팩의 처방예는 다음과 같다.A prescription example of the pack among the cosmetics containing half the extract is as follows.

여기서 반하추출물은 실시예 3의 것을 말다.Here, the half extract is that of Example 3.

[제조예 6 및 비교제조예 5]Production Example 6 and Comparative Production Example 5

반하추출물을 함유한 화장료 중 엣센스의 처방예는 다음과 같다.An example of the prescription of the essence among the cosmetics containing half the extract is as follows.

여기서 반하추출물은 실시예 3의 것을 말한다.Here, the half extract refers to that of Example 3.

[비교제조예 6 및 비교제조예 7][Comparative Production Example 6 and Comparative Production Example 7]

반하추출물을 함유하는 화장료 중 크림의 처방예는 다음과 같다.A prescription example of a cream in cosmetics containing a half herb extract is as follows.

여기서 반하추출물은 비교예 4의 것을 말한다.Here, the half bottom extract says the thing of the comparative example 4.

[비교제조예 8 및 비교제조예 9][Comparative Production Example 8 and Comparative Production Example 9]

반하추출물을 함유하는 화장료 중 크림의 처방에는 다음과 같다.The formulation of the cream in the cosmetics containing half-harvest extract is as follows.

여기서 반하추출물은 비교예 4의 것을 말한다.Here, the half bottom extract says the thing of the comparative example 4.

[실험예 3]Experimental Example 3

건강한 남여 20명을 선정하여 양팔의 하박부에 직경 7mm 크기의 구멍이 6개씩 2줄로 뚫린 알루미늄 호일을 붙이고, 팔에서 10cm 떨어진 거리에서 ORIEL solar simulator 1000w를 이용하여 60mJ/cm2의 광량을 조사하였다. 조사 전에 70% 에탄올 수용액으로 조사부위를 잘 세척하였다. 조사하기 3일 전부터 조사 후 3주째까지 1일 2회씩 제조예 2,3,6, 및 비교제조예 1,2,5,6,7,8,9,에 따라 제조된 반하추출물을 함유한 시료와 반하추출물이 함유되지 않은 기제를 한 쌍으로 같은 줄에 도포하였다. 각각에 대하여 제조예와 비교제조예의 색소침착도를 육안으로 판정하고, 제조예가 비교제조예에 비해 색소침착을 억제한 정도를 뚜렷한 효과, 효과 있음, 차이없음의 3단계로 평가하였으면, 그 결과는 표 3과 같다.20 healthy males and females were placed in the lower arm of each arm with 6 holes of 7 mm diameter in two rows of aluminum foil, and 60mJ / cm 2 light was irradiated with a ORIEL solar simulator 1000w at a distance of 10 cm from the arm. . The irradiation site was washed well with 70% ethanol aqueous solution before irradiation. Sample containing semi-extracts prepared according to Preparation Examples 2,3,6, and Comparative Preparation Examples 1,2,5,6,7,8,9, twice a day from 3 days before irradiation to 3 weeks after irradiation. Base and half-free extracts were applied to the same row in pairs. For each, the pigmentation degree of the production example and the comparative production example were visually determined, and the evaluation of the degree of suppression of the pigmentation of the production example compared to the comparative production example was evaluated in three stages of distinct effects, effects, and no differences. Table 3 is as follows.

위의 표 3의 결과에서 볼 수 있듯이, 실시예 3을 사용하여 제조된 제조예 2,3,6,에 따라 제조된 반하의 수용성 분획 추출물 함유 화장료는 피시험자 20명 중에서 최소 10명이상에 대하여 미백효과를 나타내었으며, 어떤 부작용도 나타나지 않아, 개선된 반하의 수용성 분획 추출물이 안전하고 효과가 매우 뛰어난 기미나 주근깨 개선 또는 피부미백제임을 알 수 있다. 또한 제품에서도 정제시료를 이용하여 제품의 색상이나 제형에 문제가 없었다. 그러나, 비교예 4를 사용하여 제조된 비교제조예 6에서는 제조예 2와 같은 현저한 미백효과를 나타내지 않으며, 이는 반하에 함유된 흑화성분에 의해 미백효과가 상쇄하기 때문이다. 또 비교제조예 8과 같이 농도를 10배(1% 함량)높여도 미백효과를 인식할 수 없었으며, 특히 제품이 어두운 갈색을 띠며 제형에도 문제가 있고 일부는 자극성을 호소하였다. 그러나 실시예 3을 제조예 2,3,6에서는 어떤 부작용도 나타나지 않아 반하의 수용성 분획 추출물이 안전하고 효과가 매우 뛰어난 기미나 주근깨 개선 또는 피부미백제임을 알 수 있다.As can be seen from the results in Table 3 above, the half water-soluble fraction extract-containing cosmetics prepared according to Preparation Examples 2, 3 and 6, prepared using Example 3, were used for at least 10 of 20 subjects. It showed a whitening effect and did not show any side effects, indicating that the improved water-soluble fraction extract of the improved half was safe and very effective in improving freckles or freckles or skin whitening agents. In addition, there was no problem in the color or formulation of the product using a purified sample in the product. However, Comparative Preparation Example 6 prepared using Comparative Example 4 does not exhibit the same remarkable whitening effect as Preparation Example 2, because the whitening effect is canceled by the blackening component contained in the lower half. In addition, even if the concentration was increased 10 times (1% content) as in Comparative Preparation Example 8, the whitening effect was not recognized. Particularly, the product was dark brown, and there was a problem with the formulation, and some of the irritants were appealed. However, in Example 3, Preparation Examples 2, 3, and 6 do not show any side effects, it can be seen that the water-soluble fraction extract of the contrary is a safe and highly effective freckles or freckles improvement or skin lightening agent.

Claims (3)

반하를 물 또는 무수의 탄소수 1~4의 저급 알코올,에틸아세테이트 또는 아세톤으로 1회 이상 추출하고 추출액을 감압 농축하는 단계; 상기 농축액에 정제수를 가하고 물과 섞이지 않는 극성도가 3.0 이상인 극성 유기용매를 첨가하여 분획을 실시하여 유기용매 분획을 제거하는 단계; 상기 유기용매 분획이 제거된 수용성 분획을 건조하는 단계에 의해 제조되는 것을 특징으로 하는 반하 추출물의 수용성 분획 추출물.Extracting half or more times with water or anhydrous lower alcohol, ethyl acetate or acetone having 1 to 4 carbon atoms and concentrating the extract under reduced pressure; Adding purified water to the concentrate and adding a polar organic solvent having a polarity of 3.0 or more that is not mixed with water to perform fractionation to remove the organic solvent fraction; Aqueous fraction extract of Banja extract, characterized in that it is prepared by drying the water-soluble fraction from which the organic solvent fraction is removed. 제1항에 있어서, 극성 유기용매 분획을 제거한 수용성 분획 추출물을 추가로 알칼리로 pH 6.0~13.0으로 조정하여 침전물을 얻는 방법으로 제조되는 것을 특징으로 하는 반하 추출물의 수용성 분획 추출물.The method of claim 1, wherein the water-soluble fraction extract of the half organic extract is prepared by a method of obtaining a precipitate by further adjusting the water-soluble fraction extract from the polar organic solvent fraction to pH 6.0 ~ 13.0 with an alkali. 제1항 또는 제 2항의 추출물을 건조 중량으로 0.0001~10중량% 함유하는 것을 특징으로 하는 기미, 주근깨 개선 및 피부 미백용 조성물.The composition for improving blemishes, freckles and skin whitening, characterized in that it contains 0.0001 to 10% by weight of the extract of claim 1 or 2 as a dry weight.
KR1019960007789A 1995-03-21 1996-03-21 Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof KR100190989B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960007789A KR100190989B1 (en) 1995-03-21 1996-03-21 Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR101995005997 1995-03-21
KR1019950005997A KR960033440A (en) 1995-03-21 1995-03-21 Half extract and composition containing the same
KR95-5997 1995-03-21
KR1019960007789A KR100190989B1 (en) 1995-03-21 1996-03-21 Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof

Publications (2)

Publication Number Publication Date
KR960033442A KR960033442A (en) 1996-10-22
KR100190989B1 true KR100190989B1 (en) 1999-06-15

Family

ID=66217630

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1019950005997A KR960033440A (en) 1995-03-21 1995-03-21 Half extract and composition containing the same
KR1019960007790A KR0180689B1 (en) 1995-03-21 1996-03-21 Skin whitening composition
KR1019960007789A KR100190989B1 (en) 1995-03-21 1996-03-21 Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof

Family Applications Before (2)

Application Number Title Priority Date Filing Date
KR1019950005997A KR960033440A (en) 1995-03-21 1995-03-21 Half extract and composition containing the same
KR1019960007790A KR0180689B1 (en) 1995-03-21 1996-03-21 Skin whitening composition

Country Status (1)

Country Link
KR (3) KR960033440A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200125831A (en) * 2019-04-25 2020-11-05 제너럴바이오(주) COMPOSITION FOR SKIN WHITENING CONTAINING CALLUS EXTRACT FROM Pinellia ternata AND ITS CULTURE MEDIUM

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100982435B1 (en) 2008-02-25 2010-09-15 인하대학교 산학협력단 A skin whiting composition containing ?2Z??Z??matricaria acid methyl ester as an active ingredient
KR100914963B1 (en) * 2009-04-27 2009-09-02 주식회사 바이오랜드 Composition for skin whitening comprising the extract of angelica dahurica, prunus mume, pinellia ternata, and artemisiae anomalae

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200125831A (en) * 2019-04-25 2020-11-05 제너럴바이오(주) COMPOSITION FOR SKIN WHITENING CONTAINING CALLUS EXTRACT FROM Pinellia ternata AND ITS CULTURE MEDIUM
KR102234296B1 (en) * 2019-04-25 2021-04-01 제너럴바이오(주) COMPOSITION FOR SKIN WHITENING CONTAINING CALLUS EXTRACT FROM Pinellia ternata AND ITS CULTURE MEDIUM

Also Published As

Publication number Publication date
KR0180689B1 (en) 1999-03-20
KR960033440A (en) 1996-10-22
KR960033442A (en) 1996-10-22
KR960033443A (en) 1996-10-22

Similar Documents

Publication Publication Date Title
KR102255580B1 (en) Cosmetic composition comprising Ilex paraguayensis extract and Tranexamic acid
KR0180688B1 (en) Skin whitening composition using extracts from asparagus cochinchinensis merrill
KR100190992B1 (en) A skin whitening composition containing extracts of asparagus cochinchinensis and tyrosinase inhibitor
KR100190989B1 (en) Water soluble fraction extracts of pinelliae tuber having improved skin whitening effects by removing darkening components and a composition for improvining freckles and skin whitening containing thereof
KR100530669B1 (en) Cosmetic Compositions Comprising Lactate and Glycyrrhiza Uralensis Extracts for Skin Whitening
KR100744948B1 (en) Cosmetic Composition for Skin Whitening Comprising Extract of Ramulus mori and Tetrahydrocurcumin as Active Ingredients
KR100546735B1 (en) Skin Whitening Composition
KR100466379B1 (en) Composition for skin whitening
US8986758B2 (en) Method for extracting a traditional herbal medicine component using a polished-rice steaming method
JP4772190B2 (en) Skin lightening agent
KR101176526B1 (en) Cosmetic Composition Comprising the extract of Spiraea prunifolia var.simpliciflora as Active Ingredient
KR20090117364A (en) Cosmetic composition for whitening of the skin comprising the extract of brucea javanica as active ingredient
KR101061722B1 (en) Cosmetic composition for skin whitening containing light green color extract as an active ingredient
KR100829718B1 (en) Cosmetic Composition for Whitening the Skin Comprising the Extract of Ilex rotunda as Active Ingredient
KR100681700B1 (en) Cosmetic composition for skin whitening comprising senkyunolide a and gluconic acid as active ingredients
KR100825929B1 (en) Oriental medicine plant extract having whitening effect, manufacturing method thereof and cosmetics comprising the oriental medicine plant extract
KR100453217B1 (en) Skin whitener
KR100542446B1 (en) A cosmetic composition containing an extract of capsosiphon fulvescens
KR20100088463A (en) Cosmetic composition for whitening the skin comprising the extract of aronia melanocarpa as active ingredient
KR20090119340A (en) Cosmetic composition for whitening of the skin comprising the extract of rubia cordifolia as active ingredient
KR100585468B1 (en) Cosmetic composition containing extracts of Calyx kaki, Lasiophaera Seu Calvatin or Fructus polygoni Hydropiper
KR100654959B1 (en) The cosmetic composition for skin whitening
KR20030086933A (en) A cosmetic composition containing an Extract of Zostera Marina L.
KR20000038844A (en) Whitening cosmetic base composition comprising mung bean extract
KR101006341B1 (en) Cosmetic Composition for Whitening of the Skin Comprising the Extract of Changium smyrnioides Wolff as Active Ingredient

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20071108

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee